Marker Therapeutics Inc (MRKR)

[Gatta-git-it]

An oncologist, Dr.Stephan Hahn, heads the FDA as its commissioner.
Yesterday, in a positive action, the FDA gave EUA ( Emergency Use Authorization) to Convalescence plasma as a therapeutic treatment for CV -19.
FDA tools available:
" Right to try"
EUA
Fast Track
Orphan drug status.

I can only hope that our VP in charge of FDA approval process is doing everything possible to move the TPIV pipeline and MRKR pipeline forward for approval. I hope for a change in attitude regarding much better communications with the medical practitioners, the shareholders, and the public.
Are either of these or both probable?